Search research articles
Contact Us
Filters
Showing results (111-120 of 154) with videos related to
Page
of 16
Sort By:
Clinical Chemistry
|
September 1, 1986
The "intelligent workstation" for cell-surface phenotyping based on principles of pattern recognition and image analysis
J E Goin, T M Craven, J R Gilbert, et al.
Journal of Clinical Microbiology
|
February 7, 2001
Agilent 2100 bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuni flagellin gene
I Nachamkin, N J Panaro, M Li, et al.
Clinical Science (London, England : 1979)
|
October 24, 2001
Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerols
E K Naderali, M J Brown, L C Pickavance, et al.
Clinical Chemistry
|
May 1, 1997
Diagnosis of Duchenne/Becker muscular dystrophy and quantitative identification of carrier status by use of entangled solution capillary electrophoresis
P Fortina, J Cheng, M A Shoffner, et al.
Clinical Endocrinology
|
February 24, 2012
A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus
S K Thondam, D J Cuthbertson, B S Aditya, et al.
Expert Review of Anticancer Therapy
|
November 1, 2019
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib
Christopher P Wilding, Mark L Elms, Ian Judson, et al.
Diabetes Research and Clinical Practice
|
June 12, 2008
Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention
Jonathan E Shaw, Naresh M Punjabi, John P Wilding, et al.
International Journal of Obesity (2005)
|
January 13, 2017
What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?
D J Cuthbertson, T Steele, J P Wilding, et al.
European Journal of Clinical Investigation
|
June 1, 1997
Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus
J F Todd, J P Wilding, C M Edwards, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 13, 2001
DOP-PCR amplification of whole genomic DNA and microchip-based capillary electrophoresis
P Fortina, J Cheng, L J Kricka, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 154) with videos related to
Sort By:
Page
of 16
Clinical Chemistry
|
September 1, 1986
The "intelligent workstation" for cell-surface phenotyping based on principles of pattern recognition and image analysis
J E Goin, T M Craven, J R Gilbert, et al.
Journal of Clinical Microbiology
|
February 7, 2001
Agilent 2100 bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuni flagellin gene
I Nachamkin, N J Panaro, M Li, et al.
Clinical Science (London, England : 1979)
|
October 24, 2001
Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerols
E K Naderali, M J Brown, L C Pickavance, et al.
Clinical Chemistry
|
May 1, 1997
Diagnosis of Duchenne/Becker muscular dystrophy and quantitative identification of carrier status by use of entangled solution capillary electrophoresis
P Fortina, J Cheng, M A Shoffner, et al.
Clinical Endocrinology
|
February 24, 2012
A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus
S K Thondam, D J Cuthbertson, B S Aditya, et al.
Expert Review of Anticancer Therapy
|
November 1, 2019
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib
Christopher P Wilding, Mark L Elms, Ian Judson, et al.
Diabetes Research and Clinical Practice
|
June 12, 2008
Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention
Jonathan E Shaw, Naresh M Punjabi, John P Wilding, et al.
International Journal of Obesity (2005)
|
January 13, 2017
What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?
D J Cuthbertson, T Steele, J P Wilding, et al.
European Journal of Clinical Investigation
|
June 1, 1997
Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus
J F Todd, J P Wilding, C M Edwards, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 13, 2001
DOP-PCR amplification of whole genomic DNA and microchip-based capillary electrophoresis
P Fortina, J Cheng, L J Kricka, et al.
Page
of 16